Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y Yatabe

Akt Kinase-Interacting Protein1, a Novel Therapeutic Target for Lung Cancer With EGFR-activating and Gatekeeper Mutations

Cancer Research

Molecular Biology

English

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

British Journal of Cancer

Cancer Research

English

Related publications

Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations

OncoTargets and Therapy

English

EGFR Kinase Domain Mutations – Functional Impact and Relevance for Lung Cancer Therapy

Cancer Research

Molecular Biology

English

DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases

Journal of Cellular and Molecular Medicine

Molecular Medicine

English

Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer

Cancer Research

Cancer Research

English

Cotargeting EGFR and Autophagy Signaling: A Novel Therapeutic Strategy for Non-Small-Cell Lung Cancer

Molecular and Clinical Oncology

Cancer Research

English

Allosterically Targeting EGFR Drug-Resistance Gatekeeper Mutations

Journal of Thoracic Disease

Respiratory Medicine

English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery

English

Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line

Multidisciplinary

English

OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations

Journal of Thoracic Oncology

Respiratory Medicine

English